DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $40,000 | -56.5% | 8,156 | -45.9% | 0.00% | -60.0% |
Q2 2019 | $92,000 | -3.2% | 15,083 | -8.1% | 0.01% | -54.5% |
Q1 2019 | $95,000 | -58.7% | 16,420 | -4.1% | 0.02% | -60.7% |
Q4 2018 | $230,000 | -37.5% | 17,123 | -9.6% | 0.06% | -22.2% |
Q3 2018 | $368,000 | -30.7% | 18,951 | -8.8% | 0.07% | -32.1% |
Q2 2018 | $531,000 | -11.1% | 20,773 | -29.9% | 0.11% | -15.2% |
Q1 2018 | $597,000 | +95.7% | 29,649 | +95.1% | 0.12% | +108.3% |
Q4 2017 | $305,000 | -41.0% | 15,193 | -39.2% | 0.06% | -36.2% |
Q3 2017 | $517,000 | +117.2% | 24,991 | +55.1% | 0.09% | +118.6% |
Q2 2017 | $238,000 | -26.3% | 16,113 | -20.5% | 0.04% | -12.2% |
Q1 2017 | $323,000 | +559.2% | 20,268 | +1028.5% | 0.05% | +716.7% |
Q1 2016 | $49,000 | -89.2% | 1,796 | -86.5% | 0.01% | -87.2% |
Q4 2015 | $455,000 | +42.6% | 13,311 | +19.8% | 0.05% | +46.9% |
Q3 2015 | $319,000 | -21.8% | 11,115 | +22.0% | 0.03% | -8.6% |
Q2 2015 | $408,000 | +67.2% | 9,110 | +29.2% | 0.04% | +75.0% |
Q1 2015 | $244,000 | – | 7,050 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |